Citation Impact
Citing Papers
Tumor imaging by means of proteolytic activation of cell-penetrating peptides
2004 StandoutNobel
Effects of Vascular Endothelial Growth Factor on the Lymphocyte-Endothelium Interactions: Identification of Caveolin-1 and Nitric Oxide as Control Points of Endothelial Cell Anergy
2007
Ror2 signaling regulates Golgi structure and transport through IFT20 for tumor invasiveness
2017 Standout
Collimation of astrophysical jets by inertial confinement
1992 StandoutNatureNobel
(-)-Epigallocatechin-3-gallate inhibits growth of gastric cancer by reducing VEGF production and angiogenesis
2007
Cancer Invasion and the Microenvironment: Plasticity and Reciprocity
2011 Standout
Pericytes are required for blood–brain barrier integrity during embryogenesis
2010 StandoutNature
Inflammation and cancer
2002 StandoutNature
Discoveries in structure and physiology of mechanically activated ion channels
2020 StandoutNatureNobel
Stromal fibroblasts in cancer initiation and progression
2004 StandoutNature
Genes that mediate breast cancer metastasis to the brain
2009 StandoutNature
The Blood-Brain Barrier in Health and Chronic Neurodegenerative Disorders
2008 Standout
Recent developments in constitutive receptor activity and inverse agonism, and their potential for GPCR drug discovery
2006
Extracellular matrix, inflammation, and the angiogenic response
2010
Effects of tea polyphenols on signal transduction pathways related to cancer chemoprevention
2004
Dietary Polyphenols and the Prevention of Diseases
2005 Standout
High-resolution crystal structure of human protease-activated receptor 1
2012 StandoutNatureNobel
Cancer Metastasis: Building a Framework
2006 Standout
Epigallocatechin‐3‐gallate decreases VEGF production in head and neck and breast carcinoma cells by inhibiting EGFR‐related pathways of signal transduction
2002
Binding and entry of respiratory syncytial virus into host cells and initiation of the innate immune response
2003
Survey of the year 2004 commercial optical biosensor literature
2005
Possible mechanisms of the cancer‐preventive activities of green tea
2006
Strategies for MMP inhibition in cancer: innovations for the post-trial era
2002
P‐glycoprotein in blood–brain barrier endothelial cells: interaction and oligomerization with caveolins
2003
Fyn is a novel target of (−)‐epigallocatechin gallate in the inhibition of JB6 Cl41 cell transformation
2007
Vascular Endothelial Growth Factor and Angiogenesis
2004 Standout
Regulated portals of entry into the cell
2003 StandoutNature
Expression of Vascular Endothelial Growth Factor Receptor 1 in Bone Marrow-derived Mesenchymal Cells Is Dependent on Hypoxia-inducible Factor 1
2006 StandoutNobel
The biology of VEGF and its receptors
2003 Standout
Green tea catechin, epigallocatechin‐3‐gallate, inhibits vascular endothelial growth factor angiogenic signaling by disrupting the formation of a receptor complex
2005
Macrophage Diversity Enhances Tumor Progression and Metastasis
2010 Standout
Diabetic Retinopathy
2012 Standout
Integrins in angiogenesis: multitalented molecules in a balancing act
2003
Metazoan MicroRNAs
2018 Standout
Matrix Metalloproteinases and Other Matrix Proteinases in Relation to Cariology: The Era of ‘Dentin Degradomics'
2015 Standout
Leukocytes in Mammary Development and Cancer
2010
Recent advances in MMP inhibitor design
2006
Matrix Metalloproteinases: Regulators of the Tumor Microenvironment
2010 Standout
Protective effects of green tea extracts (polyphenon E and EGCG) on human cervical lesions
2003
The structure and function of G-protein-coupled receptors
2009 StandoutNatureNobel
Transport of lipids from Golgi to plasma membrane is defective in Tangier disease patients and Abc1-deficient mice
2000
Secretory and endo/exocytic trafficking in invadopodia formation: The MT1-MMP paradigm
2010
Membrane Type 1-Matrix Metalloproteinase Is Activated during Migration of Human Endothelial Cells and Modulates Endothelial Motility and Matrix Remodeling
2001
Sorafenib in Advanced Clear-Cell Renal-Cell Carcinoma
2007 Standout
A Simple Enantioconvergent and Chemoenzymatic Synthesis of Optically Active α‐Substituted Amides
2011 StandoutNobel
Caveolae: From Cell Biology to Animal Physiology
2002
Cancer immunotherapy comes of age
2011 StandoutNature
Twist, a Master Regulator of Morphogenesis, Plays an Essential Role in Tumor Metastasis
2004 Standout
Genome-Scale Identification of SARS-CoV-2 and Pan-coronavirus Host Factor Networks
2020 StandoutNobel
Survey of the year 2003 commercial optical biosensor literature
2004
GTP‐binding proteins of the Rho/Rac family: regulation, effectors and functions in vivo
2007
Membrane type-1 matrix metalloproteinase and TIMP-2 in tumor angiogenesis
2003
Rho and Rac Take Center Stage
2004 Standout
Inhibition of Lung Carcinogenesis and Effects on Angiogenesis and Apoptosis in A/J Mice by Oral Administration of Green Tea
2004
Basic and Therapeutic Aspects of Angiogenesis
2011 Standout
Cytoplasmic tail of MT1‐MMP regulates macrophage motility independently from its protease activity
2009
Understanding the hepatitis C virus life cycle paves the way for highly effective therapies
2013 StandoutNobel
Cancer prevention by tea: animal studies, molecular mechanisms and human relevance
2009 Standout
The cAMP Signaling Pathway has Opposing Effects on Rac and Rho in B16F10 Cells: Implications for Dendrite Formation in Melanocytic Cells
2003
Identification and Characterization of MAVS, a Mitochondrial Antiviral Signaling Protein that Activates NF-κB and IRF3
2005 Standout
Atherosclerosis
2000 StandoutNature
Macrophage biology in development, homeostasis and disease
2013 StandoutNature
Inhibition of carcinogenesis by polyphenols: evidence from laboratory investigations
2005
Genes that mediate breast cancer metastasis to lung
2005 StandoutNature
Tumor gelatinases and invasion inhibited by the green tea flavanol epigallocatechin-3-gallate
2001
Interleukin 2 Receptors and Detergent-Resistant Membrane Domains Define a Clathrin-Independent Endocytic Pathway
2001
VEGF in Signaling and Disease: Beyond Discovery and Development
2019 Standout
Matrix Crosslinking Forces Tumor Progression by Enhancing Integrin Signaling
2009 Standout
ERK Plays a Regulatory Role in Induction of LTP by Theta Frequency Stimulation and Its Modulation by β-Adrenergic Receptors
1999 StandoutNobel
New functions for the matrix metalloproteinases in cancer progression
2002 Standout
Secreted Versus Membrane-anchored Collagenases
2009
MicroRNA-122 plays a critical role in liver homeostasis and hepatocarcinogenesis
2012
Hepatitis C Virus RNA Functionally Sequesters miR-122
2015 StandoutNobel
A point mutation in the murine Hem1 gene reveals an essential role for Hematopoietic Protein 1 in lymphopoiesis and innate immunity
2008 StandoutNobel
β-Arrestin inhibits NF-κB activity by means of its interaction with the NF-κB inhibitor IκBα
2004 StandoutNobel
Relationships between EGFR Signaling–competent and Endocytosis-competent Membrane Microdomains
2005
Regional Selective Neuronal Degeneration after Protein Phosphatase Inhibition in Hippocampal Slice Cultures: Evidence for a MAP Kinase-Dependent Mechanism
1998
Oral Consumption of Green Tea Polyphenols Inhibits Insulin-Like Growth Factor-I–Induced Signaling in an Autochthonous Mouse Model of Prostate Cancer
2004
H 2 O 2 , a Necessary Evil for Cell Signaling
2006 StandoutScience
Piezo1 mediates angiogenesis through activation of MT1-MMP signaling
2018
Mice with mutations of Dock7 have generalized hypopigmentation and white-spotting but show normal neurological function
2009 StandoutNobel
Differential Localization of Rho Gtpases in Live Cells
2001
Observations of stellar proper motions near the Galactic Centre
1996 StandoutNatureNobel
Lysosomal cathepsin D mediates endogenous mucin glycodomain catabolism in mammals
2022 StandoutNobel
Aggregation-Induced Emission: Together We Shine, United We Soar!
2015 Standout
Hypoxia-inducible factor 1-dependent expression of adenosine receptor 2B promotes breast cancer stem cell enrichment
2018 StandoutNobel
Inhibition of Carcinogenesis by Tea
2002 Standout
Infrared speckle imaging: Data reduction with application to binary stars
1991
Biology and Clinical Development of Vascular Endothelial Growth Factor–Targeted Therapy in Renal Cell Carcinoma
2004
Pharmacogenomic and Structural Analysis of Constitutive G Protein–Coupled Receptor Activity
2006
Vascular Endothelial Growth Factor Inhibits the Development of Dendritic Cells and Dramatically Affects the Differentiation of Multiple Hematopoietic Lineages In Vivo
1998
Hypoxia Promotes Murine Bone‐Marrow‐Derived Stromal Cell Migration and Tube Formation
2003
VEGF Receptor Signal Transduction
2001
An Adenosine-Mediated Signaling Pathway Suppresses Prenylation of the GTPase Rap1B and Promotes Cell Scattering
2013
Regulation of nuclear factor κB activation by G-protein-coupled receptors
2001
Surface Plasmon Resonance Sensors for Detection of Chemical and Biological Species
2008 Standout
Subcellular targeting of oxidants during endothelial cell migration
2005
Vascular Endothelial Growth Factor Inhibits the Development of Dendritic Cells and Dramatically Affects the Differentiation of Multiple Hematopoietic Lineages In Vivo
1998
The WD40 and FYVE domain containing protein 2 defines a class of early endosomes necessary for endocytosis
2006 StandoutNobel
Matrix invasion by tumour cells: a focus on MT1-MMP trafficking to invadopodia
2009
Works of Denis Gingras being referenced
Impaired tyrosine phosphorylation of membrane type 1-matrix metalloproteinase reduces tumor cell proliferation in three-dimensional matrices and abrogates tumor growth in mice
2008
Activation of the extracellular signal‐regulated protein kinase (ERK) cascade by membrane‐type‐1 matrix metalloproteinase (MT1‐MMP)
2001
Src-mediated Tyrosine Phosphorylation of Caveolin-1 Induces Its Association with Membrane Type 1 Matrix Metalloproteinase
2004
The Antiangiogenic Agent Neovastat (Æ-941) Stimulates Tissue Plasminogen Activator Activity
2003
Matrix metalloproteinase inhibition by green tea catechins
2000
Localization of RhoA GTPase to Endothelial Caveolae-Enriched Membrane Domains
1998
Green tea polyphenol (−)-epigallocatechin 3-gallate inhibits MMP-2 secretion and MT1-MMP-driven migration in glioblastoma cells
2002
Localization of membrane-type 1 matrix metalloproteinase in caveolae membrane domains
2001
Neovastat—a novel antiangiogenic drug for cancer therapy
2003
Inverse Agonist Activity of Selected Ligands of the Cysteinyl-Leukotriene Receptor 1
2004
Tyrosine protein kinase activity in renal brush-border membranes
1992
P‐glycoprotein is localized in caveolae in resistant cells and in brain capillaries
2000
Shark Cartilage Extracts as Antiangiogenic Agents: Smart Drinks or Bitter Pills?
2000
Purification and characterization of a stimulator of plasmin generation from the antiangiogenic agent Neovastat: identification as immunoglobulin kappa light chain
2004
Platelet-Activating Factor Stimulates Interleukin-6 Production by Human Endothelial Cells and Synergizes with Tumor Necrosis Factor for Enhanced Production of Granulocyte-Macrophage Colony Stimulating Factor
1997
Phosphorylation states of Cdc42 and RhoA regulate their interactions with Rho GDP dissociation inhibitor and their extraction from biological membranes
2002
Src-dependent Phosphorylation of Membrane Type I Matrix Metalloproteinase on Cytoplasmic Tyrosine 573
2007
Æ-941 (Neovastat®): a novel multifunctional antiangiogenic compound
2001
Localization of membrane-type 1 matrix metalloproteinase in caveolae membrane domains
2001
Matrix proteinase inhibition by AE-941, a multifunctional antiangiogenic compound.
2001
Membrane-Type 1 Matrix Metalloproteinase Stimulates Cell Migration through Epidermal Growth Factor Receptor Transactivation
2007
Tyrosine phosphorylation of the vascular endothelial-growth-factor receptor-2 (VEGFR-2) is modulated by Rho proteins
2000
The Stem Cell Marker CD133 (Prominin-1) is Phosphorylated on Cytoplasmic Tyrosine-828 and Tyrosine-852 by Src and Fyn Tyrosine Kinases
2009
Subcellular distribution and guanine nucleotide dependency of COOH-terminal methylation in kidney cortex
1993
Modified shift-and-add speckle imaging algorithm
1990
Regulation of Vascular Endothelial Growth Factor Receptor-2 Activity by Caveolin-1 and Plasma Membrane Cholesterol
2003
The antiangiogenic agent neovastat (AE-941) inhibits vascular endothelial growth factor-mediated biological effects.
2002
Phosphorylation states of Cdc42 and RhoA regulate their interactions with Rho GDP dissociation inhibitor and their extraction from biological membranes
2002
Membrane type 1–matrix metalloproteinase (MT1-MMP) cooperates with sphingosine 1–phosphate to induce endothelial cell migration and morphogenic differentiation
2003
The antiangiogenic agent Neovastat (AE-941) induces endothelial cell apoptosis.
2002
Green tea catechins inhibit vascular endothelial growth factor receptor phosphorylation.
2002
Platelet-activating factor (PAF-acether) enhances the concomitant production of tumour necrosis factor-alpha and interleukin-1 by subsets of human monocytes.
1991
Regulation of Rho protein binding to membranes by rhoGDI: inhibition of releasing activity by physiological ionic conditions
1999